Professional background

Dr Fevronia Kiparissi is a consultant paediatric gastroenterologist at Great Ormond Street Hospital (GOSH) and University College London Hospitals (UCLH).

Fevronia read medicine at the University of Tübingen, Germany, before completing her training in general paediatrics and paediatric gastroenterology in the UK and Germany and at GOSH. She has worked at GOSH since 2002.

She is the lead in transition and adolescent agstroenterology at GOSH, coordinating transition of patients to UCLH and she is also the paediatric IBD lead at GOSH.

 

Research interests

  • Early onset inflammatory bowel disease
  • Paediatric and adolescent inflammatory bowel disease
  • Coeliac disease
  • Functional gastrointestinal disorder (FGID)
  • Irritable bowel disease (IBS)
  • Non IgE-mediated food allergies
  • Transition

 

Languages spoken

German, Greek

Publications

  • MSc Clinical Paediatrics/University College London 2003-2005
    Institute of Child Health
    “Prevalence of sub-clinical enteropathy in children and adolescents with type I insulin dependent diabetes mellitus in a defined geographical area in London- An autoimmune precursor of Celiac Disease?“ MSc project in Clinical Paediatrics at the Institute of Child Health/University College London

    Clinical PhD supervisor at ICH/UCL and Great Ormond Street Hospital
    1. Elucidating the mechanisms of Thromboembolism and Structural Arterial Disease in Children with Inflammatory Bowel Disease
    2. Microbiom and Immunity in Paediatric Inflammatory Bowel Disease

    Clinical Advance nurse practitioner supervisor at Great Ormond Street Hospital for 2 nurses

    Publications
    Books
    Contributor to the Oxford Handbook of 2009 and 2018
    Paediatric Gastroenterology, Hepatology and Nutrition,
    “Drug induced liver injury”

    Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel
    Richard Hansen, Susanna Meade, R Mark Beattie, Marcus KH Auth, Nick Croft, Philip Davies, David Devadason, Conor Docherty, Jenny Epstein, Lucy Howarth, Fevronia Kiparissi, Rafeeq Muhammed, Vinay Shivamurthy, Christine Spray, Michael P Stanton, Franco Torrente, Arun Urs, David Wilson, Peter M Irving, Mark Samaan, Jochen Kammermeier
    Gut. 2020 Sep : gutjnl-2020-322449.

    Blue rubber bleb nevus syndrome in a 10-year-old child treated with loop ligation facilitated by double-balloon enteroscopy
    Nikolaos Lazaridis, Alberto Murino, Nikolaos Koukias, Fevronia Kiparissi, Edward J. Despott
    VideoGIE. 2020 Sep; 5(9): 412–414.

    Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry
    Jesse Pratt, Daniel Jeffers, Eileen C. King, Michael D. Kappelman, Jennifer Collins, Peter Margolis, Howard Baron, Julie A. Bass, Mikelle D. Bassett, Genie L. Beasley, Keith J. Benkov, Jeffrey A. Bornstein, José M. Cabrera, Wallace Crandall, Liz D. Dancel, Monica P. Garin-Laflam, John E. Grunow, Barry Z. Hirsch, Edward Hoffenberg, Esther Israel, Traci W. Jester, Fevronia Kiparissi, Arathi Lakhole, Sameer P. Lapsia, Phillip Minar, Fernando A. Navarro, Haley Neef, KT Park, Dinesh S. Pashankar, Ashish S. Patel, Victor M. Pineiro, Charles M. Samson, Kelly C. Sandberg, Steven J. Steiner, Jennifer A. Strople, Boris Sudel, Jillian S. Sullivan, David L. Suskind, Vikas Uppal, Prateek D. Wali
    EGEMS (Wash DC) 2019; 7(1): 51.

    Detecting inflammation in inflammatory bowel disease - how does ultrasound compare to magnetic resonance enterography using standardised scoring systems?
    Barber JL, Zambrano-Perez A, Olsen ØE, Kiparissi F, Baycheva M, Knaflez D, Shah N, Watson TA.
    Pediatr Radiol. 2018 Jun;48(6):843-851. doi: 10.1007/s00247-018-4084-1. Epub 2018 Apr 13

    Developing a core outcome set for fistulising perianal Crohn's disease.
    Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N, McNair AGK, Hind D, Yassin N, Lobo AJ, Brown SR, Sebastian S, Phillips RKS, Lung PFC, Faiz OD, Crook K, Blackwell S, Verjee A, Hart AL, Fearnhead NS; ENiGMA collaborators.
    Gut. 2018 Feb 3. pii: gutjnl-2017-315503. doi: 10.1136/gutjnl-2017-315503. [Epub ahead of print]

    Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years
    Jochen Kammermeier, Robert Dziubak, Matilde Pescarin, Suzanne Drury, Heather Godwin, Kate Reeve, Sibongile Chadokufa, Bonita Huggett, Sara Sider, Chela James, Nikki Acton, Elena Cernat, Marco Gasparetto, Gabi Noble-Jamieson, Fevronia Kiparissi, Mamoun Elawad, Phil L. Beales, Neil J. Sebire, Kimberly Gilmour, Holm H. Uhlig, Chiara Bacchelli, Neil Shah
    J Crohns Colitis. 2017 Jan; 11(1): 60–69.

    Interleukin-10 receptor mutation presenting with severe nappy ulceration and infantile inflammatory bowel disease.
    McDonald BS, Narayanan S, Elawad M, Kiparissi F, Cullup T, Batta K.
    Clin Exp Dermatol. 2017 Oct;42(7):771-773. doi: 10.1111/ced.13157. Epub 2017 Jun 9.

    Detecting inflammation in the unprepared pediatric colon - how reliable is magnetic resonance enterography?
    Barber JL, Lozinsky AC, Kiparissi F, Shah N, Watson TA.
    Pediatr Radiol. 2016 May;46(5):646-52. doi: 10.1007/s00247-015-3538-y. Epub 2016 Feb 11.

    The role of exclusive enteral nutrition in the management of orofacial granulomatosis in children.
    Mutalib M, Bezanti K, Elawad M, Kiparissi F.
    World J Pediatr. 2016 Nov;12(4):421-424. Epub 2016 Nov 3.
    Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years.

    Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
    Pichler J1,2, Ong C2,3, Shah N2,4, Sebire N5, Kiparissi F2, Borrelli O2, Pilkington C6, Elawad M2. Pediatr Res. 2016 Jun;79(6):895-901

    OP-16 DIETARY INTERVENTION USING THE LOW FODMAP DIET VERSUS THE "MILK, EGG, WHEAT AND SOYA FREE" DIET FOR TREATMENT OF FUNCTIONAL GUT DISORDERS A SINGLE CENTRE EXPERIENCE.
    Keetarut K, Kiparissi F, McCartney S, Murray C.
    J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):516. doi: 10.1097/01.mpg.0000472220.63550.71.

    Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis.
    Volonaki E, Mutalib M, Kiparissi F, Shah N, Lindley KJ, Elawad M.
    Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1425-8. doi: 10.1097/MEG.0000000000000470.

    Eosinophilic gastrointestinal disease and inflammatory bowel disease in children: is it a disease continuum?
    Mutalib M, Blackstock S, Evans V, Huggett B, Chadokufa S, Kiparissi F, Elawad M.
    Eur J Gastroenterol Hepatol. 2015 Jan;27(1):20-3

    The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
    Mutalib M, Borrelli O, Blackstock S, Kiparissi F, Elawad M, Shah N, Lindley K.
    J Crohns Colitis. 2014 Dec 1;8(12):1730-4

    Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome.
    Cristofori F, Thapar N, Saliakellis E, Kumaraguru N, Elawad M, Kiparissi F, Köglmeier J, Andrews P, Lindley KJ, Borrelli O.
    Aliment Pharmacol Ther. 2014 Aug;40(3):309-17

    Extraintestinal manifestations in children with gastrointestinal food allergy.
    Domínguez-Ortega G, Borrelli O, Meyer R, Dziubak R, De Koker C, Godwin H, Fleming C, Thapar N, Elawad M, Kiparissi F, Fox AT, Shah N.
    J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):210-4

    Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children.
    Murch S, Jenkins H, Auth M, Bremner R, Butt A, France S, Furman M, Gillett P, Kiparissi F, Lawson M, McLain B, Morris MA, Sleet S, Thorpe M; BSPGHAN.
    Arch Dis Child. 2013 Oct;98(10):806-11

    Diagnosing coeliac disease.
    Jenkins HR, Murch SH, Beattie RM; Coeliac Disease Working Group of British Society of Paediatric Gastroenterology, Hepatology and Nutrition.
    Arch Dis Child. 2012 May;97(5):393-4

    A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.
    Russell RK, Wilson ML, Loganathan S, Bourke B, Kiparissi F, Mahdi G, Torrente F, Rodrigues A, Davies I, Thomas A, Akobeng AK, Fagbemi A, Hyer W, Spray C, Vaish S, Rogers P, McGrogan P, Heuschkel RB, Ayub N, Fell JM, Afzal NA, Green M, Murphy MS, Rao P, Shah N, Ho GT, Naik S, Wilson DC.
    Aliment Pharmacol Ther. 2011 Apr;33(8):946-53.

    Lymphocytic leiomyositis and myenteric ganglionitis are intrinsic features of cystic fibrosis: studies in distal intestinal obstruction syndrome and meconium ileus.
    Smith VV, Schäppi MG, Bisset WM, Kiparissi F, Jaffe A, Milla PJ, Lindley KJ.
    J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):42-51

    Treatment of intractable ulcerating enterocolitis of infancy by allogeneic bone marrow transplantation.
    Thapar N, Lindley KJ, Kiparissi F, Elawad MA, Ashworth M, Veys P, Gaspar HB, Hill SM, Milla PJ, Shah N.
    Clin Gastroenterol Hepatol. 2008 Feb;6(2):248-50

    UEG Week 2013 Poster Presentations
    United European Gastroenterol J. 2013 Oct; 1(1 Suppl):

    A Case of Cheilitis Granulomatosa/Orofacial Granulomatosis
    Ronald Brown, Andre Farquharson, Gail Cherry-Peppers, Leslie Lawrence, Donna Grant-Mills
    Clin Cosmet Investig Dent. 2020; 12: 219–224. Published online 2020 Jun 23. doi: 10.2147/CCIDE.S254899

    The 7th International 22q11.2 Deletion Meeting
    Ricoh Arena
    Mol Syndromol. 2011 Jan; 1(4): 192–209